Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cadence: Why FDA Approval Is Imminent
Seeking Alpha
Wednesday, February 17, 2010 - 10:27am
tags:
FDA, Cadence Pharmaceuticals
Genzyme's quarterly profit falls
Marketwatch
Wednesday, February 17, 2010 - 10:26am
tags:
Genzyme, earnings
Pfizer's Pyramid of Doom, Or How the Drugmaker Oversold the Market for Cholesterol Drugs by 28 Million Americans
BNET Pharma
Wednesday, February 17, 2010 - 9:19am
tags:
Pfizer, Lipitor, off-label, whistleblowers
Ark. announces $18.5M settlement with Eli Lilly
Google/AP
Wednesday, February 17, 2010 - 9:16am
tags:
Arkansas, settlements, Zyprexa, Eli Lilly
CSL Profit Beats Estimates on Swine Flu Vaccine Sales
Bloomberg
Wednesday, February 17, 2010 - 9:07am
tags:
earnings, CSL, swine flu, vaccines
Bristol-Myers' Damp Squib: Diabetes Drug Onglyza Nets Only $6M in Q4
BNET Pharma
Wednesday, February 17, 2010 - 9:05am
tags:
diabetes, Onglyza, Bristol-Myers Squibb
Why Teva's Dip on Earnings Is an Opportunity
Seeking Alpha
Wednesday, February 17, 2010 - 9:04am
tags:
Teva Pharmaceuticals, earnings
Teva’s MS Treatment Copaxone Chalks Up 25% Sales Gain
WSJ Online
Wednesday, February 17, 2010 - 9:01am
tags:
Teva Pharmaceuticals, Copaxone, MS, multiple sclerosis
Roche To Pay $25M Over Accutane And Bowel Disease
Pharmalot
Wednesday, February 17, 2010 - 9:00am
tags:
Roche, settlements, Accutane
Teva, Actavis Said to Be Final Ratiopharm Bidders as EQT Exits
Bloomberg
Wednesday, February 17, 2010 - 8:56am
tags:
Teva Pharmaceuticals, Ratiopharm, M&A, Actavis
Cholesterol-Cutting Drugs Raise Diabetes Risk by 9% in Study
Bloomberg
Wednesday, February 17, 2010 - 8:54am
tags:
statins, diabetes, Crestor, Lipitor, Pfizer, AstraZeneca
Merck: Studies boost Gardasil for new uses
Yahoo/AP
Wednesday, February 17, 2010 - 8:52am
tags:
Merck, Gardasil, vaccines
It's the End of Days for Celgene's Multiple-Myeloma Drug Franchise
BNET Pharma
Tuesday, February 16, 2010 - 5:11pm
tags:
Multiple Myeloma, Celgene, Revlimid
Weakening Outlook on Sanofi
Yahoo/Zacks.com
Tuesday, February 16, 2010 - 5:10pm
tags:
Sanofi
For Blockbuster Cancer Drugs, Approvals Are the Easy Part
Motley Fool
Tuesday, February 16, 2010 - 3:26pm
tags:
cancer, Pfizer, Sanofi, JNJ, Doxil, Gleevac, Novartis, Lyrica, Erbitux
ImClone Scandal: A Timeline
TheStreet.com
Tuesday, February 16, 2010 - 2:25pm
tags:
ImClone, Eli Lilly, Pfizer, Bristol-Myers Squibb
Rigel Investors Balk at AstraZeneca Deal
Minyanville
Tuesday, February 16, 2010 - 2:24pm
tags:
Rigel, AstraZeneca, partnerships
A Big Upgrade for Vical
Motley Fool
Tuesday, February 16, 2010 - 2:23pm
tags:
Vical
Merck to Slash 15% of Workforce, Save up to $3B - CBL
Citybizlist
Tuesday, February 16, 2010 - 11:01am
tags:
Merck, restructuring, layoffs
Pharma aims its brands at emerging markets
Fierce Pharma
Tuesday, February 16, 2010 - 10:52am
tags:
generics, emerging markets

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.